Comparison of Selegiline and Rasagiline Therapies in Parkinson Disease: A Real-life Study

BACKGROUND: We aimed to compare indicators of Parkinson disease (PD) progression between patients first prescribed either selegiline or rasagiline as their antiparkinsonian drugs (APDs) on the basis of real-life data. METHODS: Pharmacy data on members of a large Israeli health maintenance organizati...

Descripción completa

Detalles Bibliográficos
Autores principales: Peretz, Chava, Segev, Hagar, Rozani, Violet, Gurevich, Tanya, El-Ad, Baruch, Tsamir, Judith, Giladi, Nir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028154/
https://www.ncbi.nlm.nih.gov/pubmed/27438181
http://dx.doi.org/10.1097/WNF.0000000000000167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028154/
https://www.ncbi.nlm.nih.gov/pubmed/27438181
http://dx.doi.org/10.1097/WNF.0000000000000167

Ejemplares similares